NSE filing, NSE: SANGANI. Summary written from the filing by ALFA Finder's alert engine.
Sangani Hospitals Ltd: key numbers
- Share price
- ₹62.65
- Market cap
- ₹86.31 Cr
- Revenue (annual)
- ₹107.0 Cr
- Net profit (annual)
- ₹2.99 Cr
- P/E (TTM)
- 28.9×Sector 34.1×
- Promoter holding
- 74.09%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sangani Hospitals Ltd
All →Sangani Hospitals Other Announcement
Sangani Hospitals Limited filed its quarterly compliance certificate under SEBI Regulation 74(5), confirming no rematerialisation requests were received for the period ended 30th September 2026.
Sangani Hospitals Management Change
Sangani Hospitals Limited has appointed M/s. R G G R & Associates LLP as Statutory Auditors. The appointment is for a five-year term effective September 28, 2026.
- Execution
- 60 months
Sangani Hospitals Annual General Meeting
Sangani Hospitals Limited held its 5th Annual General Meeting on September 28, 2026, to discuss financial statements, director re-appointment, and statutory auditor appointment.
Sangani Hospitals Other Announcement
Sangani Hospitals Limited appointed M/s. R G G R & Associates LLP as the company's new statutory auditor, effective September 3, 2026.
Sangani Hospitals Annual General Meeting
Sangani Hospitals Limited will hold its Fifth Annual General Meeting on September 28, 2026. The meeting will address financial statements, director reappointment, and statutory auditor appointment.
Sangani Hospitals Board Meeting Outcome
Sangani Hospitals approved its board report, the statutory auditor appointment, and the notice for the fifth annual general meeting to be held on September 28, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.